AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 211 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $388,000 | -21.3% | 21,072 | -3.6% | 0.20% | +43.1% |
| Q1 2017 | $493,000 | -28.1% | 21,861 | +11.0% | 0.14% | -22.6% |
| Q4 2016 | $686,000 | +44.1% | 19,702 | +1.4% | 0.18% | +40.5% |
| Q3 2016 | $476,000 | -0.8% | 19,439 | -3.1% | 0.13% | -37.0% |
| Q2 2016 | $480,000 | +9.3% | 20,055 | +6.9% | 0.20% | +6.4% |
| Q1 2016 | $439,000 | +98.6% | 18,767 | +156.8% | 0.19% | +93.8% |
| Q4 2015 | $221,000 | – | 7,309 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,344,620 | $116,393,000 | 6.64% |
| Consonance Capital Management LP | 1,026,902 | $35,736,000 | 3.92% |
| FALCON POINT CAPITAL, LLC | 801,944 | $27,908,000 | 3.74% |
| Credit Capital Investments LLC | 72,813 | $2,534,000 | 3.24% |
| Crosspoint Capital Strategies, LLC | 99,274 | $3,455,000 | 3.07% |
| Camber Capital Management LP | 611,390 | $21,276,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 40,901 | $1,423,000 | 1.04% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 344,103 | $11,974,000 | 0.83% |
| STELLIAM INVESTMENT MANAGEMENT, LP | 572,500 | $19,923,000 | 0.66% |
| AlphaOne Investment Services, LLC | 66,105 | $2,301,000 | 0.64% |